Femme et Homme
- | Pays :
- Norway
- Germany
- United Kingdom
- Les 3 autres...
- | Organes : -
- | Spécialités : -
Extrait
Patients with refractory or relapsed hematologic malignancies will receive CP-4055 intravenously(IV) on Day 1-5 every three weeks until complete response or disease worsening/progressing
Critère d'inclusion
- hematologic malignancies ,AML